Patents by Inventor Ann Marien

Ann Marien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060147377
    Abstract: In a first aspect the present invention provides a tumor cell line stably transfected with an expression vector containing a reporter gene, preferably a fluorescent protein, operably linked to a promotor that also controls expression of a protein that is associated with tumor regression, stabilisation of tumor growth or inhibition of metastatic growth, characterised in that said cell line is capable to form a tumor when implanted or injected into the non-human animal. Compared to the traditional in vivo models, the present invention differs in that the reporter gene is not constitutively expressed, but only after exposure to a test compound that results in the expression of a protein or enzyme associated with tumor regression, stabilisation of tumor growth or inhibition of metastatic growth.
    Type: Application
    Filed: March 3, 2004
    Publication date: July 6, 2006
    Applicant: JANSSEN PHARMACEUTICA N.V.
    Inventors: Ann Belien, Janine Arts, Ann Marien, Annemie Valckx